Literature DB >> 21134890

Predicting in vitro drug sensitivity using Random Forests.

Gregory Riddick1, Hua Song, Susie Ahn, Jennifer Walling, Diego Borges-Rivera, Wei Zhang, Howard A Fine.   

Abstract

MOTIVATION: Panels of cell lines such as the NCI-60 have long been used to test drug candidates for their ability to inhibit proliferation. Predictive models of in vitro drug sensitivity have previously been constructed using gene expression signatures generated from gene expression microarrays. These statistical models allow the prediction of drug response for cell lines not in the original NCI-60. We improve on existing techniques by developing a novel multistep algorithm that builds regression models of drug response using Random Forest, an ensemble approach based on classification and regression trees (CART).
RESULTS: This method proved successful in predicting drug response for both a panel of 19 Breast Cancer and 7 Glioma cell lines, outperformed other methods based on differential gene expression, and has general utility for any application that seeks to relate gene expression data to a continuous output variable. IMPLEMENTATION: Software was written in the R language and will be available together with associated gene expression and drug response data as the package ivDrug at http://r-forge.r-project.org.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21134890      PMCID: PMC3018816          DOI: 10.1093/bioinformatics/btq628

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  12 in total

1.  Chemosensitivity prediction by transcriptional profiling.

Authors:  J E Staunton; D K Slonim; H A Coller; P Tamayo; M J Angelo; J Park; U Scherf; J K Lee; W O Reinhold; J N Weinstein; J P Mesirov; E S Lander; T R Golub
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

2.  Genomic signatures to guide the use of chemotherapeutics.

Authors:  Anil Potti; Holly K Dressman; Andrea Bild; Richard F Riedel; Gina Chan; Robyn Sayer; Janiel Cragun; Hope Cottrill; Michael J Kelley; Rebecca Petersen; David Harpole; Jeffrey Marks; Andrew Berchuck; Geoffrey S Ginsburg; Phillip Febbo; Johnathan Lancaster; Joseph R Nevins
Journal:  Nat Med       Date:  2006-10-22       Impact factor: 53.440

Review 3.  The NCI60 human tumour cell line anticancer drug screen.

Authors:  Robert H Shoemaker
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

4.  Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm.

Authors:  K D Paull; R H Shoemaker; L Hodes; A Monks; D A Scudiero; L Rubinstein; J Plowman; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1989-07-19       Impact factor: 13.506

5.  Sulforhodamine B colorimetric assay for cytotoxicity screening.

Authors:  Vanicha Vichai; Kanyawim Kirtikara
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

6.  A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery.

Authors:  Jae K Lee; Dmytro M Havaleshko; Hyungjun Cho; John N Weinstein; Eric P Kaldjian; John Karpovich; Andrew Grimshaw; Dan Theodorescu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-31       Impact factor: 11.205

7.  Anticancer medicines in development: assessment of bioactivity profiles within the National Cancer Institute anticancer screening data.

Authors:  David G Covell; Ruili Huang; Anders Wallqvist
Journal:  Mol Cancer Ther       Date:  2007-08       Impact factor: 6.261

8.  Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas.

Authors:  Aiguo Li; Jennifer Walling; Yuri Kotliarov; Angela Center; Mary Ellen Steed; Susie J Ahn; Mark Rosenblum; Tom Mikkelsen; Jean Claude Zenklusen; Howard A Fine
Journal:  Mol Cancer Res       Date:  2008-01-09       Impact factor: 5.852

9.  Gene selection and classification of microarray data using random forest.

Authors:  Ramón Díaz-Uriarte; Sara Alvarez de Andrés
Journal:  BMC Bioinformatics       Date:  2006-01-06       Impact factor: 3.169

10.  Utilization of genomic signatures to identify phenotype-specific drugs.

Authors:  Seiichi Mori; Jeffrey T Chang; Eran R Andrechek; Anil Potti; Joseph R Nevins
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240

View more
  65 in total

Review 1.  Integration and analysis of genome-scale data from gliomas.

Authors:  Gregory Riddick; Howard A Fine
Journal:  Nat Rev Neurol       Date:  2011-07-05       Impact factor: 42.937

2.  An in silico screen links gene expression signatures to drug response in glioblastoma stem cells.

Authors:  G Riddick; H Song; S L Holbeck; W Kopp; J Walling; S Ahn; W Zhang; H A Fine
Journal:  Pharmacogenomics J       Date:  2014-12-02       Impact factor: 3.550

3.  Active learning effectively identifies a minimal set of maximally informative and asymptotically performant cytotoxic structure-activity patterns in NCI-60 cell lines.

Authors:  Takumi Nakano; Shunichi Takeda; J B Brown
Journal:  RSC Med Chem       Date:  2020-07-20

4.  Classification and interaction in random forests.

Authors:  Danielle Denisko; Michael M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-12       Impact factor: 11.205

5.  RWEN: response-weighted elastic net for prediction of chemosensitivity of cancer cell lines.

Authors:  Amrita Basu; Ritwik Mitra; Han Liu; Stuart L Schreiber; Paul A Clemons
Journal:  Bioinformatics       Date:  2018-10-01       Impact factor: 6.937

6.  Network modeling of patients' biomolecular profiles for clinical phenotype/outcome prediction.

Authors:  Jessica Gliozzo; Paolo Perlasca; Marco Mesiti; Elena Casiraghi; Viviana Vallacchi; Elisabetta Vergani; Marco Frasca; Giuliano Grossi; Alessandro Petrini; Matteo Re; Alberto Paccanaro; Giorgio Valentini
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.379

7.  DISIS: prediction of drug response through an iterative sure independence screening.

Authors:  Yun Fang; Yufang Qin; Naiqian Zhang; Jun Wang; Haiyun Wang; Xiaoqi Zheng
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

8.  Ensemble of trees approaches to risk adjustment for evaluating a hospital's performance.

Authors:  Yang Liu; Mikhail Traskin; Scott A Lorch; Edward I George; Dylan Small
Journal:  Health Care Manag Sci       Date:  2014-04-29

9.  Chromatin Regulators as a Guide for Cancer Treatment Choice.

Authors:  Zachary A Gurard-Levin; Laurence O W Wilson; Vera Pancaldi; Sophie Postel-Vinay; Fabricio G Sousa; Cecile Reyes; Elisabetta Marangoni; David Gentien; Alfonso Valencia; Yves Pommier; Paul Cottu; Geneviève Almouzni
Journal:  Mol Cancer Ther       Date:  2016-05-16       Impact factor: 6.261

10.  Iterative sure independent ranking and screening for drug response prediction.

Authors:  Biao An; Qianwen Zhang; Yun Fang; Ming Chen; Yufang Qin
Journal:  BMC Med Inform Decis Mak       Date:  2020-09-22       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.